Abstract
Genotypic and phenotypic differences between genders: Cardiology for women.The now recognized differences between genders have had a bigger impact in cardiology, by enhancing the knowledge about the vascular wall, a key piece in the genesis of cardiovascular risk in women. These genomic differences begin in fetal life, and add themselves to the changes in life style generating the differences between genders. One consequence of the interaction of this factors it’s the accumulation of lipids in the arterial wall, increasing atherosclerosis and the risk for atherothrombosis. This process it’s facilitated in women whom after menopause develop a pro-atherogenic dismetabolia, wich leads to a bigger risk of cardiovascular damage. In western world, coronary disease occupies the first place in morbidity and mortality. In women, including those who live in latinamerican countries, morbidity and mortality reaches 50% of the total of both genders. As an example, in Colombia one woman dies every 20 minutes, all year long, due to cardiovascular causes. Cardiovascular problems in women usually present 10 years later than they do in men; acute myocardial infarction presents about 20 years later. Symptoms and clinical manifestations are not those typically seen in men and unfortunately the pharmacology, moment of diagnosis and kinds of treatment differ for women. Therefore, its important the knowledge and understanding of this differences for a precocious identification of women with augmented cardiovascular risk, evaluating its risk factors, applying the concept of global risk and making therapeutic changes in life styles. (MÉD.UIS. 2011;24(3):265-74).Key words: Cardiology. Coronary disease. Women’s Healt
References
2. Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation. 2000;102:3137–47.
3. World health statistics 2006. Geneva: World Health Organization; 2006. Available: www.who.int/whosis/whostat2006.pdf (accessed 2006 Dec 19).
4. Dustan HP. Coronary artery disease in women. Can J Cardiol. 1990;6 Suppl B:19B–21B.
5. Wenger NK. Coronary heart disease in women: an overview (myths, misperceptions and missed opportunities). In: Wenger NK, Speroff L, Packard B, eds. Cardiovascular disease and health in women. Greenwich, CT: LeJacq Communications, 1993:21–9.
6. Federman DD. The biology of human sex differences. N Engl J Med. 2006; 354:1507-14.
7. Bello N, Mosca L. Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis. 2004;46:287-95.
8. World Health Organization Statistical Information System 2004. Disponible en: www.who.int/whosis.
9. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596-601.
10. World Health Organization. Changes in death rates from CHD, men and women aged 35–74, between 1990 and 2000, selected countries. Web site of the British Heart Foundation], 2006. Available www.heartstats.org/temp/Figsp1.
11. Stramba-Badiale M, Priori SG. Gender-specific prescription for cardiovascular diseases? Eur Heart J. 2005;26:1571-2.
12. American Heart Association. Heart Disease and Stroke Statistics—2008 Update. Dallas, Tex: American Heart Association; 2008.
13. Departamento Administrativo de Estadistica. Disponible en: http://www.dane.gov.co/inf_est/vitales.htm.
14. Género, Salud y Desarrollo en las Américas – Indicadores Básicos 2005. Organización Panamericana de la Salud. Oficina Regional de la Organización Mundial de la Salud. UNFPA – UNIFEM (Fondo de Desarrollo de las Naciones Unidas para la Mujer).